U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Donanemab
INN   USAN  
Official Name English
LY 3002813
Code English
LY-3002813
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APP (AMYLOID BETA A4 PRECURSOR PROTEIN) A BETA 3-PYROGLUTAMYL PEPTIDES, A.BETA. 3 (3-X)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (84.7%)-(IGHD)-IGHJ4*01 (
Systematic Name English
DONANEMAB [USAN]
Common Name English
donanemab [INN]
Common Name English
Immunoglobulin G1, anti-(human pyroglutamyl Aβ (3-x) peptide)(human clone LY3002813 γ1-chain), disulfide with human clone LY3002813 κ-chain, dimer
Common Name English
Code System Code Type Description
CAS
1931944-80-7
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
INN
10922
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
WIKIPEDIA
Donanemab
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
USAN
LM-184
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
FDA UNII
1ADB65P1KK
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
NCI_THESAURUS
C166484
Created by admin on Sat Dec 16 14:52:27 GMT 2023 , Edited by admin on Sat Dec 16 14:52:27 GMT 2023
PRIMARY
ACTIVE MOIETY
Donanemab
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966